
Please try another search
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. The company offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. It provides bone polypeptide, oxytocin, heparin sodium, and posterior pituitary injection products; and metformin hydrochloride enteric-coated tablets, glimepiride tablets, calcium dobesilate products, and pioglitazone hydrochloride dispersible tablets. In addition, the company engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular and cerebrovascular drug; and distributes blood products. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou City, China.
Name | Age | Since | Title |
---|---|---|---|
Huasheng Huang | 54 | 2021 | Independent Director |
Weidong Zhang | 62 | 2021 | Independent Director |
Kai Qiu | 56 | 2023 | Chairman of the Board |
Guiling Tan | 58 | 2017 | Non-Employee Representative Supervisor |
Li Zhao | 68 | 2021 | Independent Director |
Jiao Zhou | 46 | 2024 | Chairman of the Supervisory Board |
Yuxuan Pan | 41 | 2024 | Director |
Huacheng Liang | 43 | 2021 | VP, CFO, Secretary & Director |
Hui Ren | 47 | 2024 | VP & Director |
Xiaoming Liang | 58 | 2021 | President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review